FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relate to field of pharmaceutics and deal with pharmaceutically stable compositions, which contain human antibody, specifically bound with human interleukine 6 (hIL-6R) receptor, where said human antibody is contained in concentration from 5 to 200 mg/ml and includes variable region of light chain with amino acid succession SEQ ID NO:26, histidine, arginine, sucrose, polysorbate.
EFFECT: group of inventions ensure considerable degree of antibody stability after storing for several months.
22 cl, 8 ex, 28 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STABILIZED PREPARATIONS CONTAINING ANTIBODIES AGAINST NGF | 2011 |
|
RU2700174C2 |
| STABILIZED PREPARATIONS CONTAINING ANTIBODIES AGAINST NGF | 2019 |
|
RU2728575C1 |
| ANTIBODY COMPOSITION | 2015 |
|
RU2743681C2 |
| FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES | 2013 |
|
RU2683861C2 |
| ANTIBODY-BASED FORMULATIONS | 2015 |
|
RU2704611C2 |
| COMPOSITIONS WITH REDUCED OXIDATION | 2014 |
|
RU2707092C2 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| COMPOSITIONS WITH REDUCED OXIDATION | 2014 |
|
RU2707550C2 |
| ANTIBODY-CONTAINING COMPOSITIONS | 2009 |
|
RU2563179C2 |
